You are here: Industry Insights > antibody

News List

Regular infusions of a novel antibody may suppress HIV for four months europeanpharmaceuticalreview
April 19, 2019
Regular infusions of a novel antibody may suppress HIV for four months.
Weekly Infusion May Be Effective, Easier HIV Therapy drugs
April 18, 2019
The advent of highly active antiretroviral therapy (HAART) in the 1990s revolutionized HIV/AIDS treatment.
WuXi Biologics, I-Mab Biopharma Ink Long-term Strategic Pact contractpharma
April 17, 2019
WuXi to provide CMC development and commercial manufacturing.
Kymab announces Merck exec Simon Sturge as new CEO pharmafile
April 11, 2019
Kymab announces Merck exec Simon Sturge as new CEO.
Computer-designed vaccine elicits potent antibodies against RSV worldpharmanews
March 11, 2019
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus (RSV) has been designed in an international research effort.
Jury upholds Amgen's patents on Repatha® (evolocumab) worldpharmanews
March 01, 2019
Amgen (NASDAQ:AMGN) announced that a Delaware jury delivered a verdict in Amgen's favor upholding the validity of two Amgen patents related to PCSK9 antibodies.
Experimental Drug Helps Women With Deadly Type of Breast Cancer drugs
February 21, 2019
An experimental drug has shown promise in extending the lives of women suffering from a particularly aggressive and deadly type of breast cancer, according to the results of a phase 2 trial....
AbCellera and Novartis enter into multi-target partnership pharmaceutical-technology
February 15, 2019
Canada-based AbCellera has announced it has signed a multi-year, multi-target agreement with Novartis under which its antibody discovery technology will be leveraged by the Swiss pharma giant for up to ten clinically-relevant disease targets....
ICR unveils efficacious cancer drug with new mechanism of action pharmaceutical-technology
February 13, 2019
Researchers from the Institute of Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust have announced promising results from a phase I/II into tisotumab vedotin (TV) in patients with one of six, drug-resistant cancers....
I-Mab Biopharma gets USFDA IND nod for antibody TJD5 biospectrumasia
January 24, 2019
China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page